Latest Period
Q1 2026
Security Snapshot
REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH) Institutional Ownership
CUSIP: 76152G209
13F Institutional Holders and Ownership History from Q4 2025 to Q2 2026
Institutions Reporting
34
Shares (Excl. Options)
2,920,029
Price
$0.73
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- RVPH on OTC
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 2,920,029
- Total 13F value
- $2,130,374
- Portfolio coverage rank
- 0%
- Share change
- +2,767,748
- Value change
- +$2,019,208
- Number of holders
- 34
- Shares outstanding
- 13,081,585
- SEC-reported price per share
- $0.54
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 76152G209.
- 34 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 34 to 4 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $2,130,374 to $3,414.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 34 institutions filings for Q1 2026.
Security key
76152G209
Latest holder period
Q1 2026
13F holders
34
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
RVPH full holder history
REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC filings
REVIVA PHARMACEUTICALS HOLDINGS, INC. company facts
REVIVA PHARMACEUTICALS HOLDINGS, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 76152G209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
RVPH
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTEGRATED CORE STRATEGIES (US) LLC | 8.2% | $579,253 | 1,072,690 | Integrated Core Strategies (US) LLC | 30 Jun 2026 |
As of 31 Mar 2026, 34 institutional investors reported holding 2,920,029 shares of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, par value $0.0001 per share (RVPH). This represents 22% of the company’s total 13,081,585 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
22%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 6.1% | 793,948 | 0% | $579,344 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 5.8% | 762,236 | 0.04% | $556,204 | |
| ARMISTICE CAPITAL, LLC | 4.5% | 592,079 | 0.01% | $432,040 | |
| GSA CAPITAL PARTNERS LLP | 2% | 261,898 | 0.01% | $191,000 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.9% | 117,568 | 0% | 0% | $85,825 |
| Warberg Asset Management LLC | 0.69% | 90,772 | 0.02% | $66,218 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.56% | 72,992 | 0% | $53,265 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.33% | 43,002 | 0% | $31,379 | |
| Virtu Financial LLC | 0.25% | 32,905 | 0% | $24,000 | |
| VANGUARD FIDUCIARY TRUST CO | 0.24% | 31,598 | 0% | 0% | $23,067 |
| STATE STREET CORP | 0.15% | 19,160 | 0% | $13,981 | |
| BlackRock, Inc. | 0.14% | 18,582 | 0% | $13,559 | |
| HRT FINANCIAL LP | 0.14% | 18,423 | 0% | $13,000 | |
| Castleview Partners, LLC | 0.12% | 15,694 | 0.01% | $11,452 | |
| TWO SIGMA INVESTMENTS, LP | 0.08% | 10,715 | 0% | $7,819 | |
| NORTHERN TRUST CORP | 0.08% | 10,469 | 0% | $7,639 | |
| MORGAN STANLEY | 0.07% | 8,530 | 0% | $6,224 | |
| UBS Group AG | 0.04% | 5,269 | 0% | $3,846 | |
| Vanguard Global Advisers, LLC | 0.02% | 3,115 | 0% | 0% | $2,274 |
| GROUP ONE TRADING LLC | 0.02% | 3,109 | 0% | $2,269 | |
| Tower Research Capital LLC (TRC) | 0.02% | 2,193 | 0% | $1,600 | |
| Sound Income Strategies, LLC | 0.01% | 1,500 | 0% | $1,215 | |
| OSAIC HOLDINGS, INC. | 0.01% | 1,219 | 0% | $889 | |
| Larson Financial Group LLC | 0.01% | 833 | 0% | $608 | |
| TD Waterhouse Canada Inc. | 0% | 625 | 0% | $498 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
3
Latest
Q1 2026
Rows shown
1-3 of 3